TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Net Income

Annual figures by fiscal year, from SEC filings.

2011: -$10.82M2012: -$11.74M2013: -$26.09M2014: -$36.38M2015: -$49.78M2016: -$74.98M2017: -$166.99M2018: -$201.81M2019: -$97.17M2020: -$143.55M2021: -$269.11M2022: -$233.66M2023: -$209.25M2024: -$51.74M2025: -$22.68M-$22.68M
2011Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$22.68M+56.2%
2024-$51.74M+75.3%
2023-$209.25M+10.4%
2022-$233.66M+13.2%
2021-$269.11M-87.5%
2020-$143.55M-47.7%
2019-$97.17M+51.9%
2018-$201.81M-20.9%
2017-$166.99M-122.7%
2016-$74.98M-50.6%
2015-$49.78M-36.9%
2014-$36.38M-39.4%
2013-$26.09M-122.2%
2012-$11.74M-8.5%
2011-$10.82M—